American Psychiatric Association (1993) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
Andersen, P. K.
Gill, R. D.
et al (1993) Statistical Methods Based on Counting Processes. New York: Springer-Verlag.
Beekman, A. T.
Copeland, J. R. & Prince, M. J. (1999) Review of community prevalence of depression in later life. British Journal of Psychiatry, 174, 307–311.
Kastrup, M. & Rafaelsen, O. J. (1986) Minicompendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatrica Scandinavica, 73, 1–37.
et al (1997) Citalopram and fluoxetine in major depression. Comparison of two clinical trials in a psychiatrist setting and in general practice. Clinical Drug Investigation, 14, 77–89.
Brown, S. L.
Salive, M. E.
Guralnik, J. M.
et al (1995) Antidepressant use in the elderly: association with demographic characteristics, health-related factors, and health care utilization. Journal of Clinical Epidemiology, 48, 445–453.
CPMP Guidelines (1991) Clinical evaluation of antidepressant drugs. Circular 2825, (Rev. 7).
Flint, A. J. & Rifat, S. L. (1999) Recurrence of first-episode geriatric depression after discontinuation of maintenance antidepressants. American Journal of Psychiatry, 56, 943–945.
et al (1998) Dose-response efficacy of paroxetine in preventing depressive recurrences: a randomised, double-blind study. Journal of Clinical Psychiatry, 59, 229–232.
McCue, R. E. & Cooper, T. B. (1989) A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Archives of General Psychiatry, 46, 783–786.
Goldman, A. L. & Hillman, D. W. (1992) Exemplary data: Sample size and power in the design of event-time clinical trials. Controlled Clinical Trials, 13, 256–271.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Clinical Global Impressions (028-CGI). Rockville, MD: United States Department of Health, Education and Welfare, 217–222.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Isaksen, P. M.
et al (2001) Prophylactic effect of citalopram in unipolar, recurrent depression: Placebo-controlled study of maintenance therapy. British Journal of Psychiatry, 178, 304–310.
Kennedy, S. H.
Eisfeld, B. S.
Dickens, S. E.
et al (2000) Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. Journal of Clinical Psychiatry, 61, 276–281.
Kyle, C. J.
Petersen, H. E. H. & Overø, K. F. (1998) Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice. Depression and Anxiety, 8, 147–153.
Montgomery, S. A. (1994) Clinically relevant effect sizes in depression. European Neuropsychopharmacology, 4, 283–284.
Montgomery, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Montgomery, S. A.
et al (1988) The prophylactic efficacy of fluoxetine in unipolar depression. British Journal of Psychiatry, 153 (suppl. 3), 69–76.
Noble, S. & Benfield, P. (1997) Citalopram. A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs, 8, 410–431.
Pollock, B. G. (1999) Adverse reactions of antidepressants in elderly patients. Journal of Clinical Psychiatry, 60, 4–8.
Quitkin, F. M. (1992) Methodology of measuring the efficacy of antidepressants. Psychopharmacology, 106, S87–S89.
Reynolds, C. F. III, Frank, E. & Perel, J. M. (1994) Maintenance therapies in late-life depression. Neuropsychopharmacology, 10, 61S.
Reynolds, C. F. III, Frank, E.
Kupfer, D. J.
et al (1996) Treatment outcome in recurrent major depress on: A post hoc comparison of elderly (“young old”) and mid-life patients. American Journal of Psychiatry, 153, 1288–1292.
Reynolds, C. F. III, Frank, E.
Perel, J. M.
et al (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. JAMA, 281, 39–45.
Robert, P. & Montgomery, S. A. (1995) Citalopram in doses of 20–60 mg is effective in depression relapse prevention: a placebo-controlled 6 month study. International Clinical Psychopharmacology, 10, 29–35.
SAS Institute Inc. (1997) SAS/STAT Software: Changes and Enhancements through Release 6.12. 1167 pp.
Small, G. W. (1998) Treatment of geriatric depression. Depression and Anxiety, 8, 32–42.
Amsterdam, J. D.
Quitkin, F. M.
et al (1999) Changes in adverse events reported by patients during 6 months of fluoxetine therapy. Journal of Clinical Psychiatry, 60, 389–394.